This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology, Other  • Alert me on articles by topic

edited by Jeffrey A. Cohen, MD, and Richard A. Rudick, MD, 928 pp, $299.95, ISBN-10: 1-84184-525-6, London, England, Informa Healthcare, 2007.

Reinhard Hohlfeld, MD, Reviewer

Arch Neurol. 2007;64(11):1670-1671.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The field of multiple sclerosis (MS) therapeutics is burgeoning. This means that it is very difficult to find one's way through the jungle of the ever-increasing number of potentially promising treatments. The book Multiple Sclerosis Therapeutics, edited by Jeffrey A. Cohen, MD, and Richard A. Rudick, MD, now in its third edition, is an excellent guide for orientation not only for MS experts, but also for neuroimmunologists and neurologists in general.

The book is remarkably comprehensive and up-to-date. In essence, it is a detailed treatise on MS therapy, comprising more than 800 pages. The list of contributors features no less than 100 names, including an impressive number of internationally renowned experts. The book is abundantly illustrated with excellent figures and instructive tables.

The introductory section addresses immunological and imaging aspects insofar as they are related to MS treatment. The second section details various aspects of . . . [Full Text of this Article]

AUTHOR INFORMATION